The Driving and Vehicle Licensing Agency (DVLA) will now allow people with diabetes who hold Group 2 licences to use continuous glucose monitoring to monitor their blood glucose levels when driving.

We take a look at some of the exciting diabetes research developments announced in August, and what the findings could mean for people living with or affected by diabetes.

The first ever immunotherapy for type 1 diabetes has been licensed for use in the UK. The Medicines and Healthcare products Regulatory Agency (MHRA) has decided teplizumab, also known as Tzield, is ...

We explain what causes gestational diabetes, what the most common risk factors are and how you can take steps to reduce your risk.

In partnership with Tesco, we surveyed 2,000 people to get an insight into people’s understanding and awareness of diabetes.

On Thursday 3 July the government published its 10 Year Health Plan, setting out its ambition to rebuild the NHS and bring care closer to home.

Lucy, our Head of Research Impact and Communications, shares the moment she was diagnosed with type 1 diabetes. And how research has revealed that her journey with type 1 began long before any ...

Our new research shows that 97% of people from South Asian, Black African and Black Caribbean communities in the UK have experienced some kind of diabetes-related stigma.

Our new data shows that an urgent intervention is needed in diabetes care and type 2 diabetes prevention to lower the number of people living with diabetes or prediabetes. Save for later Page saved!

The medical device manufacturer Owen Mumford has announced that it will stop producing its Autopen range of insulin delivery pens. Here, we look at what this means for people with diabetes who might ...

Some people who have followed a Mediterranean diet have lost weight and gone into type 2 diabetes remission. Find out more here.

We are calling for access to earlier care for people with diabetes, and a renewed government focus on preventing type 2 diabetes, following a new report that reveals the NHS is in a “critical ...